Aegirbio: Brandon Steele

Swedish diagnostics firm Aegirbio has named Brandon Steele as its new chief commercial officer, responsible for leading the firm's commercial efforts in the US. Steele most recently served as VP of global commercial operations at San Diego-based companion diagnostics developer Invivoscribe. He also held various senior management, sales, and marketing roles at IncellDx, Applied Imaging, Nanogen, Gen-Probe, and Bayer Diagnostics and began his career at Baxter International.